Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease

Abel Esteves Soares; Michael Maes; Paula Godeny; Andressa Keiko Matsumoto; Décio Sabbatini Barbosa; Taysa Antonia F. da Silva; Flávio Henrique M.O. Souza; Vinícius Daher Alvares Delfino

doi:10.1016/j.lfs.2017.10.028

Back

Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease

Elaine Ku, Lesley A. Inker, Hocine Tighiouart, Charles E. McCulloch, Ogechi M. Adingwupu, Tom Greene, Raymond O. Estacio, Mark Woodward, Dick de Zeeuw, Julia B. Lewis, Thierry Hannedouche, Tazeen H. Jafar, Enyu Imai, Giuseppe Remuzzi, Hiddo J.L. Heerspink, Fan Fan Hou, Robert D. Toto, Philip Kam‐Tao Li, Mark J. Sarnak

Article2003

Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.

Roberto Pisoni, Rita Faraone, Piero Ruggenent, Giuseppe Remuzzi

Letter2020

ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19

Yueying Wang, Gary Tse, Guangping Li, Professor Gregory Lip, Tong Liu

Article2005

Practical Recommendations for the Use of ACE Inhibitors, Beta-Blockers, Aldosterone Antagonists and Angiotensin Receptor Blockers in Heart Failure: Putting Guidelines into Practice

John J.V. McMurray, Alain Cohen‐Solal, Rainer Dietz, Eric J. Eichhorn, Leif Erhardt, Richard Hobbs, Henry Krum, Aldo Maggioni, Robert S. McKelvie, Ileana L. Piña, Jordi Soler‐Soler, Karl Swedberg

Article2006

Efficacy of Angiotensin Receptor Blockers in Cardiovascular Disease

Aldo Maggioni